These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

118 related items for PubMed ID: 1333544

  • 1. [Evaluation of new antitubercular agents--new quinolone agents].
    Kawahara S, Eirei J.
    Kekkaku; 1992 Oct; 67(10):679-82. PubMed ID: 1333544
    [No Abstract] [Full Text] [Related]

  • 2. [Evaluation of new antitubercular agents--new quinolones].
    Kawahara S, Eirei J.
    Kekkaku; 1992 Oct; 67(10):679-82. PubMed ID: 1453572
    [No Abstract] [Full Text] [Related]

  • 3. [2 cases of drug-resistant pulmonary tuberculosis treated with ofloxacin].
    Krasucka-Kluźniak A, Krakówka P.
    Pneumonol Pol; 1989 Apr; 57(4):249-52. PubMed ID: 2516906
    [Abstract] [Full Text] [Related]

  • 4. [Maxaquin in the combined treatment of tuberculosis].
    Sokolova GB, Mozhokina GN, Kunichan AD, Elistratova NA, Perel'man MI.
    Probl Tuberk; 2000 Apr; (5):35-9. PubMed ID: 11077850
    [Abstract] [Full Text] [Related]

  • 5. [Resistance of Mycobacterium tuberculosis to the major antitubercular drugs in pulmonary tuberculosis in children and youth previously untreated].
    Mordyński K, Piotrowski Z, Szymański A.
    Gruzlica; 1968 Aug; 36(8):715-8. PubMed ID: 4972465
    [No Abstract] [Full Text] [Related]

  • 6. [Resistance to antitubercular agents in patients with pulmonary tuberculosis treated in the period from 1967 to 1970].
    Marsenić B, Panajotović H.
    Plucne Bolesti Tuberk; 1974 Aug; 26 Suppl 2():60-7. PubMed ID: 4216923
    [No Abstract] [Full Text] [Related]

  • 7. In vitro activities of the newly synthesised ER-2 against clinical isolates of Mycobacterium tuberculosis susceptible or resistant to antituberculosis drugs.
    Rao SS, Raghunathan R, Ekambaram R, Raghunathan M.
    Int J Antimicrob Agents; 2009 Nov; 34(5):451-3. PubMed ID: 19625168
    [Abstract] [Full Text] [Related]

  • 8. [New antitubercular drugs].
    Krasucka-Kluźniak A.
    Pneumonol Pol; 1990 Nov; 58(4-5):163-6. PubMed ID: 2168041
    [No Abstract] [Full Text] [Related]

  • 9. [Drug resistance of Mycobacterium tuberculosis. Behavior of the phenomenon during the past 10 years].
    Daddi G, Lucchesi M, Maldarizzi B, Mancini P, Termine A.
    Ann Ist Carlo Forlanini; 1969 Nov; 29(4):286-300. PubMed ID: 5004328
    [No Abstract] [Full Text] [Related]

  • 10. Comparative in vitro activities of the new quinolone nemonoxacin (TG-873870), gemifloxacin and other quinolones against clinical isolates of Mycobacterium tuberculosis.
    Tan CK, Lai CC, Liao CH, Chou CH, Hsu HL, Huang YT, Hsueh PR.
    J Antimicrob Chemother; 2009 Aug; 64(2):428-9. PubMed ID: 19454523
    [No Abstract] [Full Text] [Related]

  • 11. [Clinical research: course of pulmonary tuberculosis caused by polyresistant Mycobacterium tuberculosis].
    Daddi G, Lucchesi M, Mancini P, Matzeu M, Rossi P.
    Ann Ist Carlo Forlanini; 1969 Aug; 29(4):330-8. PubMed ID: 5004331
    [No Abstract] [Full Text] [Related]

  • 12. [Epidemiologic aspects of resistance to ATA (Antitubercular Agents)].
    Zrilić V, Muzikravić T.
    Plucne Bolesti Tuberk; 1974 Aug; 26 Suppl 2():29-37. PubMed ID: 4216919
    [No Abstract] [Full Text] [Related]

  • 13. [Drug resistance of tubercle bacilli isolated from sputum in previously untreated pulmonary tuberculosis. 3].
    Nakai H, Maekawa N, Nakanishi M, Kawai M, Naito M.
    Bull Chest Dis Res Inst Kyoto Univ; 1971 Jan; 4(1):15-24. PubMed ID: 5005481
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Resistance problems in Mycobacteria tuberculosis and the treatment of severe tuberculosis with secondary antitubercular agents].
    Vojtek J, Holecková R, Rozánek R, Starosta V, Strnad M, Sebests J, Strusa V.
    Sb Ved Pr Lek Fak Karlovy Univerzity Hradci Kralove; 1965 Jan; 8(5):589-92. PubMed ID: 4955225
    [No Abstract] [Full Text] [Related]

  • 16. [Primary resistance in the area of the District of Split].
    Giunio N.
    Plucne Bolesti; 1986 Jan; 38(2):144-6. PubMed ID: 3097689
    [No Abstract] [Full Text] [Related]

  • 17. [Factors relating to the incidence of drug resistance for anti-tuberculosis drugs during chemotherapy. 2].
    Yamamoto M.
    Kekkaku; 1970 Nov; 45(11):359-66. PubMed ID: 4992936
    [No Abstract] [Full Text] [Related]

  • 18. [Evaluation of secondary chemoresistance of Koch bacillus at the present time].
    Jemna I, Lego I.
    Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol; 1981 Nov; 30(4):243-4. PubMed ID: 6278569
    [No Abstract] [Full Text] [Related]

  • 19. [Drug resistance of Mycobacterium tuberculosis and its significance in the hospital practice].
    Rudoĭ NM.
    Probl Tuberk; 1996 Nov; (3):6-8. PubMed ID: 8754863
    [Abstract] [Full Text] [Related]

  • 20. [Epidemiological, microbiological and clinical significance of primary drug resistance in Mycobacterium tuberculosis (collective study)].
    Rudoĭ NM.
    Probl Tuberk; 1974 Nov; (10):1-6. PubMed ID: 4213757
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.